November 12, 2008

Arbitration Clause Stricken By Court of Appeals

The 2nd U.S. Circuit Court of Appeals has issued a ruling which begins to chip away at the anti-consumer arbitration clauses used by many credit card companies to deny justice to consumers. The court held that plaintiffs could not be forced into arbitration because American Express was not a signatory to the MasterCard, Visa and Diners Club credit card agreements that

In the multidistrict currency conversion case, cardholders are claiming that card companies and major issuing banks have engaged in a Sherman Act conspiracy to fix higher fees for transactions involving foreign currency. The plaintiffs charged in their complaint that American Express conspired with other major card companies "to fix, maintain, and conceal the artificially inflated" foreign currency fees. They alleged that American Express conspired against them in part by holding a series of meetings on including compulsory arbitration agreements to thwart consumer litigation.

The 2nd Circuit reversed a lower court decision in favor of American Express. It held that arbitration is a matter of contract, but the plaintiffs did not enter into a contract with American Express, let alone any contract containing an arbitration clause.
The question for the court then became whether it would employ any one of a number of common law principles that would allow a nonsignatory to enforce an arbitration agreement, including equitable estoppel. The Court held that this was not allowable.

American Express spokesperson Joanna Lambert said the company was disappointed in the decision and was reviewing its options. American Express has recently become a bank holding company under the “bailout plan” in order to recoup losses from taxpayers for poor business practices it has employed in the past.

November 8, 2008

Georgia Injury Lawyers Will Closely Watch A Dangerous Drugs Case

Georgia injury lawyers will closely watch an upcoming U.S. Supreme case having to do with dangerous drugs and the doctrine of pre-emption. The Supreme Court is scheduled to hear arguments today in a case that has major implications for consumers who have been harmed by prescription medications. Drugmaker Wyeth Pharmaceuticals and the Bush administration are challenging a $6.7 million verdict to a Vermont musician whose arm was amputated after medical staff improperly administered the Wyeth-produced drug Phenergan. Wyeth and the administration argue people who are harmed by drugs approved by the Food and Drug Administration should not be able to pursue damages under state laws. At issue is whether the federal government can limit lawsuits by consumers who have been harmed by prescription medications. In the case before the Supreme Court a Vermont jury awarded the plaintiff $6.7 million, agreeing that Wyeth should have been clearer in its warning label about the risks of improperly administering the drug. Wyeth and the administration, however, are asking the court to rule that drug makers may not make changes to labels without the approval of the Food and Drug Administration and that people cannot sue under state law for harm caused by an FDA-approved drug. In other words, if the FDA has approved the labeling, the drug manufacturer is immune from suit. In recent years, the Bush administration and business groups have aggressively pushed limits on lawsuits through the doctrine of pre-emption - asserting the primacy of federal regulation over rules that many times differ from state to state and which often provide greater consumer protection than what is afforded them under federal law, in federal courts.

July 29, 2008

Beware Medical Credit Cards

Many doctors and dentists are marketing medical credit cards to their patients. Doctors like the cards because they get paid immediately from the credit card companies rather than spending time collecting medical bills. Doctors and other health care providers are pushing the cards even in cases where the patient needs emergency care and may not be in a position to refuse the card or to intelligently make a proper financial decision.

Consumer lawyers report they are seeing a growing number of cases where patients say they did not realize they had signed up for a credit card, nor did they understand its terms and conditions. Some of these cards carry interest rates of up to 27 percent. Like other credit cards, medical credit cards often have low or zero interest for an introductory period.

In most cases, consumer protection laws like the Truth in Lending Act would only apply to the credit card companies. However, these cards could lead to claims against the doctors under some state laws.

The issue of has become enough of a problem that in California a bill has been introduced to prohibit dentists from offering financing to patients while under anesthesia.

Credit card companies marketing these cards include Citi Health Card, GE CareCredit and Chase Health Advance. Even some hospitals, physician and dental practices have begun issuing their own branded credit cards.

In many cases, patients think they are being offered a payment plan by the medical provider, not a credit card by a commercial bank